Prognostic value of fully-automatic Metabolic Tumor Volume calculation for patients with metastatic lung cancer treated with immunotherapy

被引:0
|
作者
Humbert, O. [1 ]
Tricarico, P. [1 ]
Cheze-Le-Rest, C. [2 ]
Pace-Loscos, T. [1 ]
Ferrari, V. [1 ]
Lamazou, G. [3 ]
El Jurdi, R. [3 ]
Schalck, E. [3 ]
机构
[1] Antoine Lacassagne Canc Ctr, Nice, France
[2] CHU, Poitiers, France
[3] EuraNova, Marseille, France
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-163
引用
收藏
页码:S74 / S74
页数:1
相关论文
共 50 条
  • [41] Prognostic understanding and barriers to palliative care in patients with metastatic lung cancer on immunotherapy.
    Steffen, Laurie
    Lycan, Thomas
    Levine, Beverly J.
    Gabbard, Jennifer
    Ruiz, Jimmy
    Grant, Stefan C.
    Blackstock, A. William
    Weaver, Kathryn E.
    Petty, William J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (34)
  • [42] Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy (vol 12, e007628, 2024)
    Tricarico, P.
    Chardin, D.
    Martin, N.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [43] Prognostic Value of Time To Progression vs. Tumor Volume Doubling Time in Patients with Adenoid Cystic Carcinoma Metastatic To The Lung
    Sousa, L. G.
    Dal Lago, E. Andreazza
    Yang, Z.
    Hoff, C. O.
    Bonini, F.
    Sawyer, M.
    Wang, K.
    Lewis, W.
    Wahid, K. A.
    Hanna, E. Y.
    El-Naggar, A. K.
    Fuller, C. D.
    Kundu, S.
    Godoy, M.
    Ferrarotto, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E80 - E81
  • [44] Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT)/Concurrent Chemoradiotherapy (CCRT)
    Yabuki, Kenichiro
    Shiono, Osamu
    Komatsu, Masanori
    Sano, Daisuke
    Nishimura, Goshi
    Takahashi, Masahiro
    Taguchi, Takahide
    Inoue, Tomio
    Oridate, Nobuhiko
    PLOS ONE, 2015, 10 (02):
  • [45] Circulating tumor cells enumeration and characterization in patients with lung cancer treated with immunotherapy
    Raphael, Jacques
    Breadner, Daniel Adam
    Warner, Andrew
    Black, Morgan
    Goodale, David
    Vincent, Mark David
    Kwan, Keith
    Blanchette, Phillip S.
    Slade, Megan
    Gupta, Santosh
    Wenstrup, Rick
    Allan, Alison L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] Prognostic Value of Neutrophil to Lymphocyte Ratio for Metastatic NSCLC Patients Treated with Immunotherapy and Ramucirumab Plus Docetaxel
    Fughhi, I.
    Bonomi, P.
    Fidler, M. J.
    Basu, S.
    Borgia, J.
    Batus, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S677 - S677
  • [47] Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy
    Dosani, M.
    Yang, R.
    McLay, M.
    Wilson, D.
    Liu, M.
    Yong-Hing, C. J.
    Hamm, J.
    Lund, C. R.
    Olson, R.
    Schellenberg, D.
    CURRENT ONCOLOGY, 2019, 26 (01) : E57 - E63
  • [48] Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
    Soydal, C.
    Yuksel, C.
    Kucuk, O. N.
    Okten, I.
    Ozkan, E.
    Erdogan, B. Doganay
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S363 - S363
  • [49] Prognostic Value of Metabolic Tumor Volume Measured by F-18-FDG PET/ CT in Esophageal Cancer Patients
    Soydal, Cigdem
    Yuksel, Cabir
    Kucuk, Ozlem N.
    Okten, Ilker
    Ozkan, Elgin
    Erdogan, Beyza Doganay
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2014, 23 (01) : 12 - 15
  • [50] Metabolic Tumor Volume Is Superior to Gross Tumor Volume in Predicting Outcomes in Patients With Oropharyngeal Cancer Treated With IMRT
    Romesser, P.
    Riaz, N.
    Lok, B. H.
    Setton, J.
    Rao, S.
    Lee, N. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S474 - S474